JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB145522

TPCA 1, IkappaB kinase inhibitor

Be the first to review this product! Submit a review

|

(4 Publications)

MW 279.29 Da, Purity >98%. Potent, selective IκB kinase inhibitor (IC50 = 17.9 nM). Inhibits NF-κB nuclear localization. Shows anti-inflammatory effects in vivo. .
1 Images
Chemical Structure - TPCA 1, IkappaB kinase inhibitor (AB145522)
  • Chemical Structure

Lab

Chemical Structure - TPCA 1, IkappaB kinase inhibitor (AB145522)

2D chemical structure image of ab145522, TPCA 1, IkappaB kinase inhibitor

Key facts

CAS number

507475-17-4

Purity

>98%

Form

Solid

form

Molecular weight

279.29 Da

Molecular formula

C<sub>1</sub><sub>2</sub>H<sub>1</sub><sub>0</sub>FN<sub>3</sub>O<sub>2</sub>S

PubChem

9903786

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biochemical name

5-(4-Fluorophenyl)-2-ureidothiophene-3-carboxamide

Biological description

Potent, selective IκB kinase inhibitor (IC50 = 17.9 nM). Inhibits NF-κB nuclear localization. Shows anti-inflammatory effects in vivo.

Canonical smiles

C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F

InChi

InChI=1S/C12H10FN3O2S/c13-7-3-1-6(2-4-7)9-5-8(10(14)17)11(19-9)16-12(15)18/h1-5H,(H2,14,17)(H3,15,16,18)

InChiKey

SAYGKHKXGCPTLX-UHFFFAOYSA-N

IUPAC Name

2-(carbamoylamino)-5-(4-fluorophenyl)thiophene-3-carboxamide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

European heart journal open 5:oeaf011 PubMed40201592

2025

Modulation of cell fate by shock wave therapy in ischaemic heart disease.

Applications

Unspecified application

Species

Unspecified reactive species

Michael Graber,Can Gollmann-Tepeköylü,Victor Schweiger,Jakob Hirsch,Leo Pölzl,Felix Nägele,Daniela Lener,Hubert Hackl,Sieghart Sopper,Elke Kirchmair,Sophia Mair,Jakob Voelkl,Christina Plattner,Felix Eichin,Zlatko Trajanoski,Anne Krogsdam,Jonas Eder,Manuel Fiegl,Dominik Hau,Ivan Tancevski,Michael Grimm,John P Cooke,Johannes Holfeld

Nature 617:827-834 PubMed37165186

2023

EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia.

Applications

Unspecified application

Species

Unspecified reactive species

Sevval Nur Bilgic,Aylin Domaniku,Batu Toledo,Samet Agca,Bahar Z C Weber,Dilsad H Arabaci,Zeynep Ozornek,Pascale Lause,Jean-Paul Thissen,Audrey Loumaye,Serkan Kir

The Journal of experimental medicine 219: PubMed36098746

2022

Induction of natural IgE by glucocorticoids.

Applications

Unspecified application

Species

Unspecified reactive species

Jaechul Lim,Erica V Lin,Jun Young Hong,Bharat Vaidyanathan,Steven A Erickson,Charles Annicelli,Ruslan Medzhitov

Reproduction (Cambridge, England) 159:503-511 PubMed32103820

2020

IFNT-independent effects of intrauterine extracellular vesicles (EVs) in cattle.

Applications

Unspecified application

Species

Unspecified reactive species

Keigo Nakamura,Kazuya Kusama,Atsushi Ideta,Kazuhiko Imakawa,Masatoshi Hori
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com